Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lisa Beth Weissmann, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Satyanarayana G, Enriquez KT, Sun T, Klein EJ, Abidi M, Advani SM, Awosika J, Bakouny Z, Bashir B, Berg S, Bernardes M, Egan PC, Elkrief A, Feldman LE, Friese CR, Goel S, Gomez CG, Grant KL, Griffiths EA, Gulati S, Gupta S, Hwang C, Jain J, Jani C, Kaltsas A, Kasi A, Khan H, Knox N, Koshkin VS, Kwon DH, Labaki C, Lyman GH, McKay RR, McNair C, Nagaraj G, Nakasone ES, Nguyen R, Nonato TK, Olszewski AJ, Panagiotou OA, Puc M, Razavi P, Robilotti EV, Santos-Dutra M, Schmidt AL, Shah DP, Shah SA, Vieira K, Weissmann LB, Wise-Draper TM, Wu U, Wu JT, Choueiri TK, Mishra S, Warner JL, French B, Farmakiotis D. Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study. Open Forum Infect Dis. 2022 Mar; 9(3):ofac037. PMID: 35198648.
  2. Jani C, Salcicciol I, Rupal A, Al Omari O, Goodall R, Salciccioli JD, Marshall DC, Hanbury G, Singh H, Weissmann L, Shalhoub J. Trends in Breast Cancer Mortality Between 2001 and 2017: An Observational Study in the European Union and the United Kingdom. JCO Glob Oncol. 2021 Dec; 7:1682-1693. PMID: 34910553.
    Citations:    Fields:    
  3. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu CY, Desai A, de Lima Lopes G, Grivas P, Painter CA, Peters S, Thompson MA, Bakouny Z, Batist G, Bekaii-Saab T, Bilen MA, Bouganim N, Larroya MB, Castellano D, Del Prete SA, Doroshow DB, Egan PC, Elkrief A, Farmakiotis D, Flora D, Galsky MD, Glover MJ, Griffiths EA, Gulati AP, Gupta S, Hafez N, Halfdanarson TR, Hawley JE, Hsu E, Kasi A, Khaki AR, Lemmon CA, Lewis C, Logan B, Masters T, McKay RR, Mesa RA, Morgans AK, Mulcahy MF, Panagiotou OA, Peddi P, Pennell NA, Reynolds K, Rosen LR, Rosovsky R, Salazar M, Schmidt A, Shah SA, Shaya JA, Steinharter J, Stockerl-Goldstein KE, Subbiah S, Vinh DC, Wehbe FH, Weissmann LB, Wu JT, Wulff-Burchfield E, Xie Z, Yeh A, Yu PP, Zhou AY, Zubiri L, Mishra S, Lyman GH, Rini BI, Warner JL. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020 06 20; 395(10241):1907-1918. PMID: 32473681.
    Citations: 533     Fields:    Translation:HumansCellsPHPublic Health
  4. Ahmed G, Nasir HG, Hall K, Weissmann L. Validation of the Khorana Score to Assess Venous Thromboembolism and Its Association with Mortality in Cancer Patients: A Retrospective Community-based Observational Experience. Cureus. 2020 Apr 29; 12(4):e7883. PMID: 32489737.
    Citations: 1     
  5. Goldman RH, Weissmann L. A Diagnosis to Chew On. N Engl J Med. 2019 Aug 01; 381(5):466-473. PMID: 31365805.
    Citations:    Fields:    Translation:Humans
  6. Pories SE, Myers LE, Dusenbery KL, Lotz M, Weissmann L. Simplifying surveillance for breast cancer survivors. Breast J. 2019 05; 25(3):560-561. PMID: 30957343.
    Citations:    Fields:    Translation:Humans
  7. Krikorian S, Pories S, Tataronis G, Caughey T, Chervinsky K, Lotz M, Shen AH, Weissmann L. Adherence to oral chemotherapy: Challenges and opportunities. J Oncol Pharm Pract. 2019 Oct; 25(7):1590-1598. PMID: 30253725.
    Citations: 12     Fields:    Translation:Humans
  8. Weissmann LB, Corson JM, Neugut AI, Antman KH. Malignant mesothelioma following treatment for Hodgkin's disease. J Clin Oncol. 1996 Jul; 14(7):2098-100. PMID: 8683242.
    Citations: 9     Fields:    Translation:Humans
  9. Weissmann LB, Antman KH. Incidence, presentation and promising new treatments for malignant mesothelioma. Oncology (Williston Park). 1989 Jan; 3(1):67-72; discussion 73-4, 77. PMID: 2701403.
    Citations: 3     Fields:    Translation:Humans
  10. Licht JD, Weissmann LB, Antman K. Gastrointestinal sarcomas. Semin Oncol. 1988 Apr; 15(2):181-8. PMID: 3285480.
    Citations: 10     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Weissmann's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (49)
Co-Authors (14)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.